Neuroactive steroids in depression and anxiety disorders: clinical studies.
about
In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesThe role of reproductive hormones in postpartum depressionAllopregnanolone as a mediator of affective switching in reproductive mood disordersGABAergic neuroactive steroids: a new frontier in bipolar disorders?Neurosteroid transport by the organic solute transporter OSTα-OSTβ.Pathophysiology of depression: do we have any solid evidence of interest to clinicians?Progesterone turnover to its 5α-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats.Premenstrual dysphoric disorder: burden of illness and treatment update.Function and modulation of delta-containing GABA(A) receptorsReproductive Steroid Regulation of Mood and Behavior.Involvement of GABAA receptors in 5-HT1A and σ1 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.
P2860
Q24605563-DA7F83B7-6967-44F5-BC85-972EFED40F7DQ26738789-AE175710-2429-47D9-8353-F564F40013C2Q26849873-9F93BEE1-3DAF-468A-8636-CEDC351BF5ABQ26866177-93D6C24A-02D8-4DCD-9561-B1F0EC8FCCC1Q27011690-86444877-4778-4EB7-BE22-2E7E8BB0731CQ33637849-9661D8AF-6C4F-4AC8-8DE3-812F5775345FQ34145754-5C6E015C-4C65-4AC1-B97D-D72ABFB2D043Q36037910-0DEFFDC7-D15A-487D-9DF8-FF353DADA554Q36737964-14F31829-30B9-4F60-8127-74C8DF8B1674Q37600250-42CD0FFC-8C92-4140-99AD-B3258D01876AQ38878217-01DF200C-E184-4BC4-8348-170D5500F8AFQ47416679-6CCC8A70-1FB5-4B6E-9EDD-2500ACF61559Q47691179-8C978170-F173-45FE-BD44-FDE98CE83418Q47877573-FE60A818-D356-4EE8-AD78-ACC623DD1012
P2860
Neuroactive steroids in depression and anxiety disorders: clinical studies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@en
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@nl
type
label
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@en
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@nl
prefLabel
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@en
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@nl
P2093
P2860
P356
P1433
P1476
Neuroactive steroids in depression and anxiety disorders: clinical studies.
@en
P2093
Cornelius Schüle
Daniela Eser
Elena Romeo
Rainer Rupprecht
Thomas C Baghai
P2860
P304
P356
10.1159/000097879
P577
2006-12-08T00:00:00Z